AzTrials
AzTrials

Ovarian CystsPhase 4NCT00713778

The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst

A Phase 4 study testing Ovarian cystectomy in people with Ovarian Cysts, run by Shandong Provincial Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cyst and the possible mechanisms. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
Conditions the study is for
Ovarian Cysts
What is being tested?
Ovarian cystectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
192 participants
Where
1 siteChina
Study dates
Nov 2003to May 2008
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-40 years
  • Uni/bilateral ovarian cyst(s) without clinical and sonographic suspicion of ovarian cancer
  • Regular menstrual cycles defined as cycle length between 25 and 35 days in the 6 months before surgery
  • Agreement to be enrolled in the study

Who cannot join

  • Prior ovarian surgery
  • Surgical necessity to perform adnexectomy
  • Known endocrine disease
  • Post operative pathologic diagnosis was not benign ovarian cyst
  • Oral contraceptive use before surgery

Trial locations and contacts

1 site in 1 country.

China1 site
  • Shandong Provincial Hospital

    Jinan, Shandong, 250021

Other trials in China

About this study

Official title: The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Exc

The purpose of this study is to investigate the impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cyst and the possible mechanisms.

Read the detailed description

Laparoscopic cystectomy is currently considered the treatment of choice in women with benign ovarian cysts and has gained increasing acceptance among gynecological surgeons(1). However, the safety of this technique in terms of ovarian damage to the operated gonad has recently been questioned. In the present study, with the combined use of serum hormonal evaluation and ultrasound examination, we planned to prospectively investigate the ovarian reserve after the excision of benign ovarian cysts. The damage to ovarian reserve will be evaluated through a 12-months follow-up after the application of bipolar, ultrasonic scalpel electrocoagulation or suture during ovarian cystectomy

Conditions
Ovarian Cysts
Being tested
Ovarian cystectomy
Keywords
Ovarian Cysts, Electrocoagulation, Ovarian Function Tests, Laparoscopy
Medical subject headings
Ovarian Cysts, Hyperthermia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ovarian cystectomyProcedure or surgery

    Also called laparoscopic ovarian cystectomy using bipolar

    Laparoscopic ovarian cystectomy using bipolar

  • Ovarian cystectomyProcedure or surgery

    Also called laparoscopic ovarian cystectomy using ultrasonic scalpel

    Laparoscopic ovarian cystectomy using ultrasonic scalpel electrocoagulation

  • Ovarian cystectomyProcedure or surgery

    Also called Laparotomic ovarian cystectomy using suture

    Laparotomic ovarian cystectomy using suture

Study groups in NCT00713778
Study groupRoleWhat they receive
1ExperimentalLaparoscopic ovarian cystectomy using bipolar
Receives: Procedure: Ovarian cystectomy
2ExperimentalLaparoscopic ovarian cystectomy using ultrasonic scalpel
Receives: Procedure: Ovarian cystectomy
3Active comparatorLaparotomic ovarian cystectomy using suture
Receives: Procedure: Ovarian cystectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serum FSH and E2 assays

    Measured: 12 months

Secondary outcomes (1)
  1. Transvaginal ultrasound examinations for basal antral follicle number, mean ovarian diameter and peak systolic velocity

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2008 (estimated)
  2. Study startNov 2003
  3. Primary completionMay 2008
  4. Study completionMay 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
192 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00713778
Sponsor's protocol ID
SPH-CL-030408
Status last verified
Jul 2008
First submitted
7 Jul 2008
Last updated
18 Aug 2008
Results posted
No
Data monitoring committee
Yes

Publications

  • Candiani M, Barbieri M, Bottani B, Bertulessi C, Vignali M, Agnoli B, Somigliana E, Busacca M. Ovarian recovery after laparoscopic enucleation of ovarian cysts: insights from echographic short-term postsurgical follow-up. J Minim Invasive Gynecol. 2005 Sep-Oct;12(5):409-14. doi: 10.1016/j.jmig.2005.06.006.

    PubMed 16213426
  • Ho HY, Lee RK, Hwu YM, Lin MH, Su JT, Tsai YC. Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation. J Assist Reprod Genet. 2002 Nov;19(11):507-11. doi: 10.1023/a:1020970417778.

    PubMed 12484492
  • Loh FH, Tan AT, Kumar J, Ng SC. Ovarian response after laparoscopic ovarian cystectomy for endometriotic cysts in 132 monitored cycles. Fertil Steril. 1999 Aug;72(2):316-21. doi: 10.1016/s0015-0282(99)00207-1.

    PubMed 10439003
  • Nargund G, Cheng WC, Parsons J. The impact of ovarian cystectomy on ovarian response to stimulation during in-vitro fertilization cycles. Hum Reprod. 1996 Jan;11(1):81-3. doi: 10.1093/oxfordjournals.humrep.a019043.

    PubMed 8671163
  • Somigliana E, Ragni G, Benedetti F, Borroni R, Vegetti W, Crosignani PG. Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod. 2003 Nov;18(11):2450-3. doi: 10.1093/humrep/deg432.

    PubMed 14585900

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Ovarian cystectomy in people with Ovarian Cysts, run by Shandong Provincial Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Aug 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serum FSH and E2 assays (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00713778, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in